Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
ALTERATION IN THE RECOMMENDED DOSING SCHEDULE FOR RISPERIDONE
Autore:
LUCHINS DJ; KLASS D; HANRAHAN P; MALAN R; HARRIS J;
Indirizzi:
UNIV CHICAGO,DEPT PSYCHIAT,MC3077,5841 S MARYLAND AVE CHICAGO IL 60637 ILLINOIS DEPT MENTAL HLTH & DEV DISABILITIES CHICAGO IL 00000
Titolo Testata:
The American journal of psychiatry
fascicolo: 3, volume: 155, anno: 1998,
pagine: 365 - 366
SICI:
0002-953X(1998)155:3<365:AITRDS>2.0.ZU;2-F
Fonte:
ISI
Lingua:
ENG
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Physical, Chemical & Earth Sciences
Science Citation Index Expanded
Citazioni:
4
Recensione:
Indirizzi per estratti:
Citazione:
D.J. Luchins et al., "ALTERATION IN THE RECOMMENDED DOSING SCHEDULE FOR RISPERIDONE", The American journal of psychiatry, 155(3), 1998, pp. 365-366

Abstract

Objective: The authors' goal was to study the recommended dose schedule for risperidone. Method: They obtained computerized pharmacy data on 1,283 inpatients with the diagnoses of schizophrenia or schizoaffective disorder who were treated with risperidone. Continuance on risperidone was defined as remaining on the drug for 16 days or until discharge. Results: The majority of the patients (84%) continued on risperidone. Use of the recommended dose schedule decreased greatly over time. Patients were more likely to continue on risperidone if they had a higher maximum dose (5.7 mg/day versus 4.7 mg/day), a longer number of days to maximum dose (5.7 days versus 3.9 days), and a maximum rise in dose of 0.5-2 mg/day. Conclusions: These findings suggest that the recommended dose schedule should be altered to one that recommends a less rapid titration (over 6 days to a week) and that the dose increments consist of 0.5-2 mg/day.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 12:30:34